Trobalt™ Products Risk Survey

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Epilepsy
Interventions
DRUG

Trobalt™

Trobalt™ is a potassium channel opener used as an adjunctive treatment for partial onset seizures (a form of epilepsy where a seizure begins in a specific area in one side of the brain), with or without secondary generalization in adults aged 18 years and above with epilepsy.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01721213 - Trobalt™ Products Risk Survey | Biotech Hunter | Biotech Hunter